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A WINDOW INTO AUTISM’S EARLY DEVELOPMENT:  
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EVALUATION IN INFANTS AT HIGH RISK FOR AUTISM 
MALGORZATA PTAK 
 
ABSTRACT 
 
Autism spectrum disorders (ASDs) are a biologically-based and behaviorally-defined 
spectrum of conditions which impact development. These conditions affect and are 
diagnosed based on features in three psychological and behavioral domains: social 
interaction, communication, and repetitive behaviors. Developing better ways to identify 
early signs of autism, whether through behavioral or other types of measures, is important 
because it will allow children to gain access to interventions and treatments earlier, which 
has demonstrated positive outcomes.  
Over the past 10 years, the prevalence of reported autism cases has increased. As a result, 
much research has focused on the etiology and phenotype of autism. Investigations 
seeking early signs of autism have generally studied vulnerable populations, particularly 
infants with an older sibling diagnosed with autism.  
Aside from observable behavioral differences, biological abnormalities, often within the 
gastrointestinal and immune systems as well as endocrine, autonomic and other systems, 
have been observed in a significant number of children diagnosed with autism. These 
features raise the possibility that cellular and tissue change in body and brain may be 
altering brain function such that behaviors emerge later and downstream of these cellular 
  vi 
and tissue problems. However, research on the pathophysiology underlying these medical 
features, and particularly regarding how they develop in infancy, has received almost no 
attention. Such investigation would require measuring pathophysiological and medical 
features alongside current standard measures of behavioral and phenotypical 
presentations of autism.  
This thesis describes a study, funded by the Department of Defense Autism Research 
Program and carried out at the Massachusetts General Hospital Lurie Center, that 
proposed to look for early markers of autism in the pathophysiological domains in high 
risk infants and place them into developmental context by correlating these observations 
(some of which might potentially become early markers) with well-established 
neurocognitive measures. The goal of the study is to find biomarkers of clinical 
importance that reflect the pathophysiologial development of autism which might 
substantially precede behavioral changes that are currently used as a standard of 
diagnosis, but are not developmentally apparent or reliably measurable until well into the 
second or third year of life. 
While the overall scope of the study encompassed a range of systemic and nervous 
system measures as well as neurocognitive assessments, the focus of this thesis is mainly 
on a subset of the behavioral and neurocognitive measures collected through the study, 
specifically the Autism Diagnostic Observation Scale (ADOS), Autism Observational 
Scale for Infants (AOSI), Mullen Scales of Early Learning (MSEL) and Vineland 
Adaptive Behavior Scales (VABS). Subject development was tracked and assessed 
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through developmental quotients (DQs) and then correlated to measures designed to 
identify autistic-like features.  
Results demonstrate that verbal development was the most significant indicator for 
autism. Additionally, delay in communication preceded problems with socialization. 
The analysis and information used for this thesis will contribute to the infrastructure 
utilized by the investigators for assessing further behavioral data. In addition, this 
behavioral data and the metrics generated in these analyses will be analyzed in relation to 
physiological data (e.g. brain, autonomic, metabolic, immune, and microbiome data). 
Tracking early biomedical development, especially alongside the current standard of 
observing behavioral development, has the potential of offering more comprehensive 
understanding of the brain-behavior-body relationship in children diagnosed with ASD, 
which can hopefully contribute to a non-invasive, more accurate, and earlier method of 
diagnosis and to the development of more treatment options. 
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INTRODUCTION 
WHAT IS AUTISM? 
Autism spectrum disorders (ASD) encompass a range (or spectrum) of biologically-based 
neurodevelopmental disorders, linked strongly to genetics, but with growing evidence for 
environmental contributions. ASDs are defined by manifestations in three domains at the 
psychological level: social interaction, communication, and repetitive or stereotypic 
behavior [1]; issues in these domains can be observed and measured to help understand 
developmental progress and target interventions. Additionally, biological abnormalities 
have been implicated. Sensory-perceptual, sleep, and motor abnormalities are pervasive, 
and a significant subset of individuals with autism have compromised gastrointestinal and 
immune systems, as well as endocrine and autonomic nervous system function; seizures 
are common. By definition, individuals diagnosed with full autism manifest the onset of 
behavioral symptoms prior to age 3, though the spectrum more broadly can include 
individuals with later onset [2]. However, intensive research is increasingly being 
conducted to identify biological and behavioral features that can be detected early in life. 
Moreover, conceptions of autism are shifting. In particular, while ASDs have been 
considered lifelong, reliable reports of remission and loss of diagnosis have now been 
made, and autism-like symptoms have been reversed in a growing number of mouse 
models of genetic disorders associated with autism [3].  
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DIAGNOSTIC FEATURES OF AUTISM – THE AUTISM PHENOTYPE 
All early symptoms vary in intensity and in the timing of onset between individuals. The 
earliest behavioral manifestations of ASD features can be seen after 6 months (Figure 1), 
however, they typically are not reliably identified until later: between 18 months to 2 
years [4, 5, 6]. The earliest behavioral symptoms are related to intersubjectivity and joint 
attention [4, 5], although recently eye-tracking problems have been documented earlier 
[7, 8].    
SOCIAL BEHAVIOR AND CHALLENGES 
Changes in behavior associated with social stimuli can be detected early. By 8 to 10 
months (Figure 1), symptoms may include poor maintenance of eye contact limited or 
absent response to their name, indifference or reduced interest in other people, as well as 
delay in babbling [5, 9, 10]. Toddlers with autism tend to have difficulty playing socially 
and will not imitate others or engage in social learning. Additionally, they may lack a 
response to parental affection and they may not seek parental support or comfort [10].  
 
Figure 1: Typical Development and the Onset of Observable Behaviors in 
Autism. Early onset of autistic-like features are typically displayed around 8 
months and social in nature. Figure adapted from: Cervera, et al (2011). 
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By the time children with autism reach 3 or 4 years of age, they begin exhibiting a failure 
to develop Theory of Mind (ToM), which usually emerges by this age and allows 
individuals to comprehend another person’s feelings and perspective [10, 11]. Emotional 
regulation can also be difficult for certain individuals with autism and is linked to 
problem behavior, which can include having outbursts that may be triggered by relatively 
mild stimuli, as well as engaging in aggressive and self-injurious behavior [10]. These 
behaviors can increase in situations which are unfamiliar, frustrating or overwhelming for 
the individual. Some research suggests that such behaviors may be related to high 
sympathetic nervous system arousal combined with sensory hypersensitivity [12, 13]. 
 
COMMUNICATION DIFFICULTIES 
One of the more observable signs in developmental delay, and in some cases of autism, is 
problems with communication and language. Children with autism tend to be delayed in 
babbling along with speaking, although children with Asperger’s syndrome may be 
precocious in their language development.  Also observed are delays in learning to use or 
interpret gestures and body language. Language loss is also very noticeable in regressive 
autism, where children start developing typically, but then regress developmentally and 
start to show signs of autism, such as diminution or loss of language or eye contact with 
others, usually between 14 months and 2 years of age [10, 15].  
 
Communication difficulties can also contribute to problem behavior, in part because of 
difficulties conveying needs and concerns. Through therapy, nonverbal children can learn 
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to communicate through pictures, sign language, or electronic word processors, such as 
computers. However, individuals with autism who do have language abilities still have 
difficulties with the pragmatics of language, including intonation, which tends to be 
atypical, as well as understanding sarcasm, metaphors, figures of speech, facial 
expressions and body language; there is a tendency to take things literally and not 
understand jokes [10]. 
 
Not maintaining joint attention also contributes to a lack of communication. This includes 
focusing on a shared activity and sharing attention on the same stimuli as another person. 
Children with ASD generally lack interest in sharing or pointing to objects, and may not 
understand or perform well at waiting for their turn to communicate with another person. 
Therapeutically, by gaining experience with successful purposeful communication and its 
usefulness as a tool to problem solving, individuals with autism can be motivated to learn 
to communicate [14, 15]. 
 
REPETITIVE BEHAVIORS AND IDIOSYNCRATIC INTERESTS  
Children with autism engage in a restrictive range of activities. This appears to be related 
to a desire to preserve sameness which leads them to feel uncomfortable when their 
environment changes. Engagement in repetitive, self-stimulating behavior, such as body 
rocking, jumping, twirling and hand flapping, is common; some observers, as well as 
articulate adults with autism, say that these behaviors help calm them down and 
compensate for their proprioceptive challenges (giving them information about where 
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they are in space) [10]. Restrictive behavior can also manifest in how children with 
autism play; for example, they can spend hours lining up toys or spinning wheels or 
objects, instead of using objects in ways related to their functions or using symbolic or 
imaginative play [14]. Repetitive behaviors can become intense idiosyncratic 
preoccupations or obsessions, involving content or depth of knowledge on specific 
narrow topics of personal interest, although some individuals, often thanks to insightful 
parents, have broadened these idiosyncratic interests enough to make employment 
possible or even to allow such individuals to make brilliant contributions to society. 
Some individuals can exhibit savant-like abilities, such as the ability to determine the day 
of the week of dates from centuries ago [10, 15]. 
 
OTHER OBSERVABLE CHALLENGES AND RELATED SYMPTOMS 
There are other comorbid problems that may accompany ASD. Children tend to have 
limited adaptive skills, such as self-care, home-skills, self-direction, community-use and 
integration, health and safety, and leisure and work [5]. Additionally, they commonly 
have sensory processing, integration and responsiveness problems as well as problems 
with fine and gross motor functioning [16, 17]. These sensory and motor challenges may 
actually be among the underlying contributors of behavioral manifestations. Certain 
stimuli, such as touch, sounds, sights, smells and tastes can be overwhelming to 
individuals with autism. Children can either be hyper- or hypo-sensitive and these stimuli 
can be experienced as painful, confusing or unpleasant [15].  Both sensory and motor 
problems can contribute to difficulty in receptive and expressive communication.  
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ASSOCIATED AND CONCURRENT MEDICAL CONDITIONS OF AUTISM 
Many children diagnosed with autism have symptoms of related medical conditions, such 
as seizures, metabolic conditions, sleep disturbances, and gastrointestinal (GI) disorders. 
These conditions significantly impact the health, development, education, and social 
well-being of these individuals. The biomedical problems observed in autism are not only 
often related to each other, but to neurobehavioral problems as well [18]. One of the more 
commonly reported concerns by parents are the presence of severe self-restriction of diet 
to a few foods, such as cheese and processed carbohydrates, as well as major and often 
painful GI problems, which may often reflect in their child’s behavior; children with 
ASD who experienced GI problems have been shown to be more irritable, with an 
increase in aggressive, repetitive, obsessive-compulsive and ritual behavior, and with 
more tantrums and sleep disturbances. Some investigators argue that there is a 
relationship between the physiology underlying these medical conditions and the 
physiology underlying brain issues in ASDs [19, 20]. 
 
DIAGNOSTIC PROCESS 
Clinical and behavioral manifestations of ASD vary in intensity and presence of 
symptoms between phenotypes [10]. The Diagnostic and Statistical Manual of Mental 
Disorders-Fifth Edition (DSM-V) distinguishes the different phenotypes of ASD based 
on severity levels [21]. Previously, autism was considered a specific subset under 
pervasive developmental disorders, which also included Asperger’s disorder and 
Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS). Though these 
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diagnostic criteria have now been replaced by severity levels, data on autism may still be 
distinguished through the DSM-IV diagnoses [22]. Additionally, there are subclinical 
autism-like characteristics, such as problems with communication, language delay, 
restricted interests, and social awkwardness, which do not meet the threshold for autism 
diagnosis, but may still be problematic for individuals with these features. These less 
severe traits are collectively considered the broader autism phenotype (BAP). BAP is 
commonly seen in family members of children diagnosed with ASD [23]. The wide 
variance in phenotype creates a challenge in diagnosis and, ultimately, in understanding 
this disorder.  
 
PRESENT CHALLENGES IN DIAGNOSIS AND EARLY DETECTION 
Current procedures for diagnosing autism are dependent on observable behavior. A 
developmental history is primarily composed through interviewing primary-care givers 
and educators of a child. Developmental and behavioral data is assessed through 
assessing which milestones have been met in communication, motor skills, social 
competence, and receptive response [5, 24]. The “gold standard” diagnostic tool typically 
used is the Autism Diagnostic Observation Schedule (ADOS), a play-based interview 
which can be complemented with another diagnostic tool, like the Autism Diagnostic 
Interview-Revised (ADI-R), a historical instrument assessing behaviors associated with 
ASDs, or a screener, such as the Social Communication Questionnaire (SCQ) [5, 14]. 
Clinically, the DSM-V could be used. Most importantly, through the process, the nature 
and (if a historical instrument is used) the time of origin of symptoms will be 
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documented. Early diagnosis and developmental assessment are necessary to provide 
financial support for access to interventions for the child and to understand which areas 
of development need intervention. 
 
Detection and early diagnosis often fails to occur because of the lack of knowledge 
among family members, educators and clinicians regarding how to recognize signs of 
autism. Many parents notice a developmental delay become concerned with their child’s 
development between 12 and 23 months of age, however, the child may not receive a 
professional diagnosis until 36 to 70 months of age [25]. This delay in the diagnosis 
prevents access to treatment and intervention. Since there is such variance in the autism 
phenotype, diagnosis can be difficult. The best intervention and treatment should be 
determined based on individual profiles. 
 
Currently, there is no proven medical or pharmacological standardized protocol for 
autism that reliably reverses and overcomes its symptoms, or even manages its core 
features. However, studies have shown that early intensive behavioral and educational 
interventions produce promising outcomes [5, 10, 26, 27], with some clinicians 
suggesting that additional biomedical treatments for medical and physiological issues 
may further improve outcomes.  
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EPIDEMIOLOGY 
ASDs affects all ethnic, socioeconomic, and age groups. The impact of the disorder 
varies depending on location and assessment or diagnostic method, and approaches in the 
US and around the world are not fully standardized. In an effort to improve this situation, 
the Centers for Disease Control and Prevention (CDC) in 2000 organized the Autism and 
Developmental Disabilities Monitoring (ADDM) Network, which uses a systemic 
screening of developmental evaluation records specific for ASD behaviors, rather than 
depending on a medical or educational diagnostic label alone. In 2014, the CDC released 
a report announcing a 30% increase of children diagnosed with ASD in America in the 
year 2010 [28]. Currently, 1 in 68 children have ASD, compared to 1 in 88 two years 
prior (Figure 2) [29]. Boys (1 in 42) are 4.5 times more likely to be diagnosed than girls 
(1 in 189); about 80% of affected individuals are male [30].  
Clinically, however, girls who are diagnosed with autism have more severe cognitive 
impairments when compared to boys with autism. The reason for this difference in 
prevalence between genders is still not fully understood; it might indicate that girls with 
ASD exhibit symptoms differently than boys, leading to underdiagnoses with current 
standards; it might also indicate differences in underlying vulnerabilities [31]. 
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Overall, studies have shown that girls tend to have better social skills than boys; girls 
diagnosed with autism scored similarly on social scales to typically developing boys, 
which might make proper assessment difficult. It is notable that although less girls are 
diagnosed with autism, the severity of girls with the diagnosis tends to be greater [31]. 
 
WHAT IS CAUSING AN INCREASE IN AUTISM PREVALENCE?  
Social factors  
An increase in prevalence might arise from a combination of contributors. Some portion 
of this increase in numbers might reflect a true increase, suggesting a growing epidemic; 
studies have shown that somewhere between forty-five percent and sixty-five percent of 
 
 
Figure 2: Rising Autism Prevalence, 2000-2010. Autism 
prevalence, as recorded through the CDC in a standardized manner 
specific for ASD, has been exponentially increasing since 2000 [29] 
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the increases cannot be attributed to social factors. The remaining 35-55% can be 
explained by geographical clustering, the increase in parental age, the increase of 
professional and public awareness of the condition, better screening, and more expanded 
diagnostic criteria [32, 33, 34].  
 
With more public awareness of ASD, parents are more likely to raise concerns about 
development, especially regarding features that could be linked with autism. 
Additionally, the screening and evaluation tools have become more reliable and widely 
used, and professionals are gaining more proficiency in recognizing signs of ASD [35]. 
This is important because this promotes earlier diagnosis, which provides earlier access 
to intervention, and therefore, results in better overall prognosis.  
 
Etiology of autism  
Of the 45-65% increase in autism prevalence not explained through social factors, the 
exact etiologic factors of autism are still unknown; ASD can have a variety of 
contributors or a combination of contributors to risk interacting with each other, such as 
genetics and environment and complex gene-environment interactions. Due to the 
variation in symptoms across the spectrum, there are most likely multiple contributing 
factors to the development of autism, resulting in several ways in which children become 
autistic that are not necessarily the same from one child to another. 
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Genetic Disorders  
There is currently a small subset of autism cases linked to specific genetic conditions 
which largely affect development or function of the brain. Currently, only 23% cases of 
autism have known genetic influences.  These include Mendelian disorders and other 
mutations (15%), rare and de novo mutations (5%), and chromosomal abnormalities (3%) 
[36, 37]. Genetic syndromes where individuals are more likely to manifest autistic 
features include: Fragile X syndrome, Angelman syndrome, Prader-Willi syndrome, 
Rett’s Syndrome, tuberous sclerosis, and Smith-Lemli-Optiz syndrome [10].  
 
Multifactorial Contributions to the Etiology of Autism 
Genes and Heredity  
ASDs have been considered to be highly heritable disorders, though more recent twin 
studies have been finding less heritability than earlier studies. It is increasingly 
appreciated that ASDs can involve multiple genes as well as a variety of environmental 
exposures or influences; this great variability likely contributes to the demonstrated 
variability in phenotype. Twin studies have demonstrated that autism is strongly genetic: 
monozygotic twin pairs share more of the autistic phenotype than dizygotic twins [38]. 
Heritability rates greatly vary from 37-76% [39, 40, 41, 42, 43, 44]. Some recent studies 
have yielded lower estimates of heritability and have suggested a greater role for 
environmental influences in etiology.   
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Additionally, features of the BAP are commonly present in the parents who have children 
diagnosed with autism. The presence of BAP in even one parent has been linked to the 
severity of autism behaviors in the children, when compared to parents with no BAP 
features. Parental age (especially older fathers) has also been linked to heritability of 
autism, though most of the effect studied has been attributed to social factors of couples 
having children later in life, rather than de novo mutations in older parents [45].  
 
Environment 
Since the concordance rate in twin studies is less than 100% and the majority of cases do 
not have a known genetic cause, the contribution of environmental factors in etiology is 
likely. Epigenetically, this combined complex genetic interaction creates susceptibility 
for the development of ASD, which is activated or aggravated through environmental 
influence. Twin studies have found that a shared environment influences heredity by 20-
58% and a non-shared environment does so by 19-43% [38, 39, 46].  
 
Additionally, both genetics and the environment have been linked to the possible 
influence on the gender ratio difference in autism. Some studies claim that girls are more 
genetically protected, such that more genetic mutations are required for girls to develop 
autism, which might also explain the severity of ASD seen in girls [31, 47]. 
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Studies are far from conclusive regarding the exact genetic and environmental 
contributors to the development of autism, moreover, contributing to the idea that there is 
great heterogeneity in contributors across the autism spectrum. However, a better 
understanding of epigenetic mechanisms along with epigenetic findings have suggested 
that both areas need to be considered to fully understand the etiology of autism. 
 
Prenatal and Postnatal Environmental Impact  
Documentation of the contribution of early environmental exposures to autism has raised 
the question of how much one can consider autism to be inborn and whether there may 
also or instead be a contribution to autism’s development over time from exposure to 
stressors. A study from 2011 has found that pregnant women, and in turn, their unborn 
babies, are exposure to nearly 200 chemicals, which were found in the placenta, cord 
blood, amniotic fluid, and meconium. Some of these chemicals, considered endocrine 
disruptors, neurodevelopmental toxicants, and carcinogens, have been banned (more in 
Europe than in the U.S.) since the 1970s, due to poor health effects [48]. Of these 
chemicals, only 20 percent have been screened for their potential in affecting a 
developing brain [49]. Endocrine influences, whether from toxicant exposure or fertility 
assistance, have been demonstrated to have unintentional consequences on a developing 
brain [50]. Furthermore, prenatal problems and complications related to infection 
(rubella, syphilis, or toxoplasmosis), drugs (cocaine, tobacco and nicotine, or alcohol) or 
maternal health problems (diabetes or hypertension) have all been linked in impeding 
proper brain development [10]. 
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Understanding these factors, including both exposures and their influences on physiology 
(immune and metabolic function) will hopefully provide answers to not only the etiology 
of autism, but hopefully also on the variance in phenotype and the timing of onset of 
autism – as well as potential routes to treatment and prevention.  
 
Pathogenesis and Pathophysiology 
Many studies have focused on the etiology and observable manifestations of autism. 
However, to fully understand this complex interaction, the pathophysiology of autism 
needs to be considered (Figure 3). Multiple systems, such as gastrointestinal, immune and 
 
Figure 3: Etiological, Pathophysiological, and Phenotypical Interaction in Autism. 
Autism is a multisystem condition with complex interactions influencing and being 
influenced by etiology, pathophysiology, and phenotype [51] 
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central nervous system, oxidative stress management, barrier regulation, circadian 
organization, and metabolic maintenance, are affected in parallel or downstream of one 
from another in autism, creating a damaging feed-forward cycle. Most physiological 
symptoms and problems, start to appear early in a child’s development and can interfere 
perhaps first with proper brain functioning and then, over a prolonged time, with the 
development of the brain [51]. 
 
High Risk populations 
Compared to the general population of neuropsychiatric conditions, siblings of children 
with autism, also referred to as baby sibs, have the highest relative risk in developing 
autism. The recurrence risk of autism for baby sibs who have one sibling diagnosed with 
ASD is 18.7%, which is about 1 in 5 children. The risk increases to about 1 in 3 children, 
or 32.5 percent [52] when there is more than one older sibling in the family affected with 
autism. This is a significant increase from the general population’s risk of developing 
autism, which is one in 68 [28]. 
 
Of the high risk baby sibs who do not get diagnosed with ASDs, it appears that one in 
five will develop the less severe BAP [52]. The high-risk baby sibs who do not display 
any visible traits of autism still share a certain endophenotype, or quantifiably shared 
traits common in families, with their siblings who are diagnosed with ASD. These traits, 
considered genetic in nature, increases their risk of developing autism or having more 
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subtle areas of dysfunction. Yet, some of these children compensate through protective 
mechanisms not fully understood, which prevent autism from developing. Some of these 
baby sibs might have no behavior indications of autism, while some might demonstrate 
minor delay earlier in development and then develop typically, with no full-scale autism-
like traits [28, 53]. 
 
Current Studies Focusing on Baby Sibs 
High risk baby sibs have been a focus of interest in studies more recently. These studies 
have allowed researchers to follow these infants from birth or early in development (often 
beginning at 4-6 months up to as late as one year of age) and identify early signs of ASD. 
Children who later develop autism start exhibiting certain features within their first year 
of life. Majority of noticeable features are particularly associated in socialization, such as 
lack of interest in social interaction and not tracking faces or following eye gaze in 
others, which are characteristics of low joint attention [54, 55, 56]. These studied social 
features tend to be associated with hallmark autism characteristics, suggesting that these 
infants are processing social information more slowly or differently. By using 
electroencephalography (EEG), a non-invasive method to measure the electrical activity 
of the brain, studies have seen these socially influenced behavioral changes as early as 6 
months [55]. EEG studies have also shown that children with autism have poorer 
coherence and ability to integrate information. EEG data in preparation for publication 
from the study providing the present set of behavioral data has shown brain difference 
between children diagnosed with autism and their undiagnosed age-matched peers as 
 18 
early as 2 weeks [57]. It is becoming conceivable that some sort of electrophysiological 
profiling might contribute to an earlier and more accurate diagnosis, or at least 
identification of increased risk. 
 
Though behaviorally, autism is diagnosed through changes in social domains, it is 
difficult to determine whether other less noticeable systems are being affected as well in 
ways less noticeable by social or psychological perception or measures. It is also possible 
that changes in socially related behaviors could be downstream effects of upstream issues 
that are not so commonly measured, including ones physiological in nature.  
 
CURRENT STUDY 
This thesis addresses a subsection of data, collected as part of a larger study, which 
proposed to look for early markers in the pathophysiological domains and yet at the same 
time, to correlate these novel potential early markers with well-established 
neurocognitive measures. 
The foundation of this study is based on these four guiding principles: 
1. Multiple physiological systems are affected in parallel or downstream, 
which results in interactive effects across systems, which may be negative 
in the setting of multiple problems or conceivably positive in the setting of 
increases in supports. 
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2. Biological markers have the potential to indicate changes before pertinent 
behaviors emerge and can be observed.  
3. A core set of biological changes are likely to occur more noticeably in 
children who get diagnosed with ASD. 
4. Autism may not be a condition that is fully determined at conception or 
birth, but rather a condition that develops over time, contingent upon the 
level of vulnerability, as well as the progressive and cumulative stressors 
from the environment, which could include diet, illness, toxic exposure, 
and family stress. 
 
The model motivating the study is that cellular and tissue change in body and brain 
maybe altering brain function such that behaviors emerge later and downstream of these 
cellular and tissue problems. The investigators purposed that if they could find systemic 
or brain pathophysiological markers in earlier stages of development than behaviors have 
been detectable, such findings would lend support to the importance of underlying 
pathophysiological mechanisms in generating autism core features and associated 
challenging behaviors.  
 
Because the study was a pilot study, one objective was to build the infrastructure that 
would allow the collection of this type of data, since this type of multisystem longitudinal 
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assessment of high risk infants had not been performed before, particularly regarding the 
integration of systemic physiological with electrophysiological data. 
 
This thesis will review a subsection of the longitudinal behavioral data, which was 
acquired in the serial longitudinal intensive multisystem assessment of high risk baby 
sibs.   
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METHODS 
 
This methods section has two parts. The first part reviews the methods by which the data 
was collected in the study itself. The second part presents the methods used in this thesis 
project to analyze the behavioral data acquired in this study. 
 
SUBJECT RECRUITMENT 
Infants at high-risk (HR) of developing autism and their mothers were recruited into the 
study from various sources: the LADDERS clinic (renamed the Lurie Center during the 
course of the study), the Boston Autism Consortium, and response to notices posted 
through a variety of community service and parent organizations and information 
sources. Infants were defined as being at high-risk if they had an older sibling diagnosed 
with ASD, as determined by an experienced clinician, as well as the Autism Diagnostic 
Observation Scale (ADOS) and the Social Communication Questionnaire (SCQ) or 
Autism Diagnostic Interview-Revised (ADI-R). Mothers with a child who met these 
criteria could enroll in the interval from their third month of pregnancy through their 
having an infant no older than nine months of age. Enrolled subjects were followed until 
the infant reached 30 months of age. A total of 20 infants and their mothers were enrolled 
in the study.  
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Subjects were not included if the older sibling diagnosed with ASD had been diagnosed 
with a known genetic or metabolic syndrome, as determined prior to enrollment in the 
study by dysmorphology and/or genetic and/or metabolic assessment. Infants were also 
excluded if they had a history of hypoxia-ischemia, apnea-bradycardia with alarm-
causing events, taking antiepileptic medication, a diagnosable genetic or metabolic 
syndrome, encephalitis, meningitis, premature birth earlier than 35 weeks of gestational 
age, and/or traumatic brain injury.  
One mother who enrolled prenatally exited the study after her child was stillborn with 
Trisomy 18. 
 
DATA COLLECTION: TIME POINTS  
This study had specific time points for data collection which were implemented starting 
when the mother/infant enrolled.  These time points were: 
 Each trimester of pregnancy 
 Birth for collection of biosamples (cord blood, samples of placenta and umbilical 
cord) 
 Infant visits for full multisystem assessment: 2 weeks, 8 weeks, 4 months, 9 
months, 14 months, 20 months, 30 months 
 Maternal visits at same the time as infant time-points where biosamples were 
taken on each postnatal infant visit during which time period the mother was still 
nursing 
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 A 6-month-old clinical visit for the infant by the study’s senior clinician, Dr. 
Margaret Bauman, to assess for emerging clinical concerns, but during which no 
biosamples were collected and no formal neurocognitive or EEG data collection 
was performed. 
 
This time points were grouped into 4 phases: prenatal, perinatal, postnatal/developmental, 
and outcome. In the prenatal phase, each trimester was included in assessment, starting 
with the trimester the mother was enrolled. During birth, or the perinatal time point, birth 
samples were collected, whenever possible. During the postnatal and developmental 
period, data was collected starting with the first of the scheduled time points, as early as 2 
weeks and then again at 8 weeks, which will assist in documenting earlier changes in 
autism than have been previously recorded. The developmental period included all time 
points in which the infant’s development was assessed: 2 weeks, 8 weeks, 4 months, 6 
months, and 9 months. Outcome, the last phase in this study, included the 20 and 30-
month time-points. During this time, in addition to collecting multisystem physiological 
and functional data and documenting further development, gold standard autism 
diagnostic instruments were administered. 
 
In addition to the planned time points, the study staff was available for additional visits at 
any point in time when the family might be noticing changes of particular concern to 
them. In this study, the 12 and 24-month time points were either due to arising concerns 
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or to missing scheduled time-points. In addition, due to the complexity of managing a 
household with one or more autistic children plus a new infant who might be developing 
similar problems, some parents had some visits at times not precisely in synchronization 
with the formal time points.  
 
Rationale for choosing the time points included the following: 1) Looking into 
developmental milestones, there is a lot of developmental variability at 6 and 12 months, 
whereas 4 months, 9 months and 14 months were less likely to be confounded by marked 
developmental transition; decisions about these time-points were made in detailed 
consultation with the noted developmental psychologist Dr. Jerome Kagan in the Harvard 
Department of Psychology,  2) These time points were also selected based on the 
availability and reliability of the assessments used to collect behavioral, diagnostic and 
psychometric information. 
 
STUDY METHODOLOGY 
Serial assessments were performed on the HR infants beginning at two weeks of age and 
on the mother beginning at enrollment, sometimes before delivery. At the time of 
enrollment, a family medical history was completed. Mothers were further assessed 
through retrospective questionnaires, and biosamples were collected including blood, 
breast milk if available, saliva, buccal swab sampling, and samples of hair and nails, to be 
sent in batches for metabolic, immune, nutritional and toxicological assessments.    
 25 
The infant evaluations of 2 and 8 weeks, and 4, 6, 9, 14, 20, and 30 months are displayed 
in Table 1. Trained research grade psychometricians administered the time-point 
appropriate, neurobehavioral and developmental psychometric and motor development 
tests under supervision by a licensed clinical psychologist and a physical therapist; these 
assessments were videotaped. Additionally, clinicians experienced in assessment, 
diagnosis and treatment of children with ASD performed medical and neurological 
examinations during each formal assessment time point. Infants’ development was also 
assessed through direct observation and questioning of the caregiver. At each visit infants 
wore wrist/ankle band electrodermal activity (EDA) monitors on all four extremities 
during the entire visit to measure sympathetic nervous system arousal (stress response), 
except when it might interfere with any particular assessment (such as assessment of 
motor function). An electroencephalogram (EEG) was performed on each formal visit 
where the standard procedure consisted of resting state recording as well as recording 
during the presentation of passive auditory and visual stimuli; EEG data recording was 
performed in the sleep state through the 9-month visit, and then also in the waking state 
when possible at older ages. Biosamples including urine, saliva, buccal swab, stool, blood 
samples (via blood spots from heel sticks), was collected at each formal study visit time 
point from the infants. Additionally, both mothers and infants had hair, nails, collected 
during those time points. Appendix 1 has a list of quantities of all tissue samples from 
both mother and child collected throughout the study. 
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MEASURES ANALYZED IN THIS THESIS 
A full list of assessments used in this study is included in Appendix 2. Due to the focus of 
this thesis on behavioral metrics and the length constraints of this project, the analysis 
mainly focused on behavioral outcomes from the diagnostic tools and assessments 
reviewed below. 
Table 1: Number of Subjects per Time-point. 
Longitudinal time-points in the study displayed 
along with the number of subjects that came at 
each time-point. 
Prenatal 1st trim 1 
 
2nd trim 5 
  3rd trim 13 
Perinatal birth 9 
 
2wks 14 
Postnatal/ 8wks 15 
Developmental* 4mos 17 
 
6mos 16 
 
9mos 19 
  14mos 15 
Outcome* 20mos 16 
 
30mos 16 
Other* 12/24mos 4 
*Mom & baby count as one per time point 
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DIAGNOSTIC 
Autism Diagnostic Observation Schedule (ADOS). 
The ADOS is a semi-structured play interview assessment administered by a trained 
examiner and used to measure severity of the core features of ASD: communication, 
social interaction, and repetitive behavior. It has strong predictive validity and 
consistently differentiates individuals in each of the three categories: Autism, Autism 
Spectrum, or Non-Spectrum. This makes it commonly used (particularly in research) for 
diagnoses [58, 59]. The tool includes four modules, which are each designed for a 
different level of language ability which is often related to age (though older individuals 
can have a total lack of language function) [58].  
 
In the study, ADOS modules 1 and 2 were administered based on a child’s verbal ability. 
The new algorithm was used, which assesses the raw score based on social affect and 
restrictive and repetitive behavior, as opposed to communication and social interaction, 
as was used in the old algorithm [60]. ADOS assessments were performed at 20, 24, 
and/or 30 months. All subjects used module 1 (no words or single words only) for months 
20 and 24. At 30 months, 4 (25%) of the subjects were assessed using module 2 (phrase 
speech), while 12 (75%) were assessed with module 1. Four subjects out of the total 20 
have not yet had an ADOS assessment.  
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Diagnostic and Statistical Manual (DSM-IV) – Symptom Checklist  
The DSM-IV checklist is a concise method of documenting present ASD core symptoms 
and features from the DSM-IV, which allows for determining whether an ASD diagnosis 
applies [1, 22]. In this study and analysis, the DSM-IV was used to confirm the diagnosis 
of the HR subjects at 30 months. 
 
NEUROCOGNITIVE AND NEURODEVELOPMENTAL 
Mullen Scales of Early Learning (MSEL): 
The Mullen Scales of Early Learning (MSEL) is a standardized and reliable assessment 
administered by an examiner to children from birth to 68 months old. It integrates five 
developmental areas to provide a comprehensive understanding of a child’s cognitive and 
motor ability through age-equivalent scores. The five subdomains assessed include visual 
reception, expressive language, receptive language, gross motor, and fine motor [61]. 
 
BEHAVIORAL 
Autism Observational Scale for Infants (AOSI) 
The AOSI is a standardized observational measure which uses semi-structured activities 
to engage the infant with the aim of detecting signs of autism as they emerge in children 
6-18 months of age. The measure is administered by a trained examiner who interacts and 
plays with the assessed infant in a way to elicit particular behaviors. These behaviors 
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focus on joint attention, social interaction and communication, behavioral reactivity, and 
sensory-motor behaviors [62]. 
An AOSI total score of 9 or above at 12 months has been demonstrated to provide a 
reliable prediction of a diagnosis of autism at age 3; because the AOSI has good 
predictive validity at 12 months [62] it was used in the present analysis to confirm 
differentiated diagnostic groups within the analysis. It was also used to correlate between 
developmental quotients between behavioral assessments. 
 
Pervasive Developmental Disorder – Behavior Inventory (PDD-BI) 
The PDD-BI is an informant-based rating scale used to assess children from 30 months to 
12 years 5 months who have been diagnosed with a pervasive developmental disorder 
(PDD) as defined by the DSM-IV; in the DSM-IV, ASD is classified as a PDD [1]. The 
test is composed of a teacher and parent-rating forms and conveys the functional ability 
of a child affected by PDD. Unlike other standard assessments, the PDD-BI assesses both 
problem behaviors associated with PDD, such as ritualistic behavior, as well as 
appropriate skills in social interaction, language and communication, and learning; it 
additionally assesses issues with sensory-related function. These areas fall under two 
major domains: approach and withdrawal problems, and receptive and expressive social 
communication abilities. Validity of the PDD-BI has been assessed through comparison 
with the ADOS and the VABS [63]. The PDD-BI was used in this project to confirm 
differentiated diagnostic groups within the analysis. 
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Vineland Adaptive Behavior Scales – Interview Edition (VABS) 
The Vineland Adaptive Behavior Scales (VABS) is a standardized caregiver interview 
which is used to assess adaptive functioning in the domains of communication (receptive 
and expressive), daily living skills (personal, domestic, and community), socialization 
(interpersonal relationships, play and leisure time, and coping skills), and motor skills 
(fine and gross) [64]. 
 
ANALYTIC STRATEGY 
The analytic strategy involved a several stage procedure, which included: calibrating raw 
assessment scores, calculating Developmental Quotients (DQs) to standardize data 
measures across tests, systematic classification regarding the autism spectrum based on 
the set of tests being considered here, and confirmation of the differential groups. 
 
Calibrating ADOS Raw Scores 
Assessing ASD severity through ADOS raw total scores, as categorized by the modules, 
provides a more standardized and differentiated diagnosis [65]. However, the ADOS is a 
poor measurement of longitudinal comparison of data over time because it was designed 
for diagnosis rather than as a measure of change, and scores are age and language 
dependent. 
Calibrating ADOS scores and standardizing the ADOS raw scores across modules can 
create a more uniform distribution across age and language [65]. This allows for 
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longitudinal comparison of data. Calibrated scores range from 1 to 10 (1-3 meaning 
typical, 4-5 meaning ASD, and 6-10 meaning autism) and reflect the severity of ASD-
related characteristics. For the present data sample, the age at which the scores were 
collected were rounded up when calibrated; the scores of children measured at 20 months 
were calibrated as if the child was evaluated at 2 years (24 months) of age and scores at 
30 months were calibrated as if the child was evaluated at 3 years (36 months) of age. 
Reasoning for this method was supported through using the AOSI at 9 months and 
correlating the scores with the ADOS calibrated scores at both 2 and 3 years old for all 
the subjects. Calibrating the ADOS at 30 months to 2 years old produced less significant 
results (p = 0.129) compared to calibrating the scores to 3 years old (p = 0.093).  
Studies have used the ADOS calibrated scale to compare across the MSEL [65, 66] and 
VABS [67] developmental quotient scores (described below). 
 
Developmental Quotients 
For the current analysis, the age-equivalent scores were converted to a developmental 
quotient (DQ), which can be used as an approximation to demonstrate development 
through IQ [68].  
An advantage of the DQ, aside from using it as a comparative metric to IQ, is that it 
avoids a possible floor and ceiling effect [69, 70]. To calculate the DQ, the subscale age-
equivalent score was divided by the child’s chronological age and then multiplied by 100. 
Aside from looking at each subdomain separately, verbal (mean of expressive and 
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receptive language) and non-verbal (mean of visual reception and fine motor) DQs were 
also calculated and used in the analysis. As is similar with IQ, a higher DQ means that 
the child scored higher than average in developmental progress in comparison to his 
peers.  
VABS DQs are weaker predictors of developmental progress [71], but for consistency in 
comparison across assessment, the DQs in each domain in the VABS have been 
calculated and used in analysis. Significance of each DQ in VABS was tested and 
compared to the MSEL DQs. 
 
Classifying Within the Spectrum 
Before performing statistical analysis, the subjects were divided into three ASD 
differential groups (Table 2), based on their assessment results on the DSM-IV, ADOS, 
AOSI, and PDD-BI, by procedures described below. These categories were created to 
discover trends in DQs indicative of autistic-like symptoms. This was done to gain a 
better and fuller understanding of the developmental trajectories of the subjects, as 
determined through the assessments.  
 
Due to gender differences in autism, it is worth considering males and females separately. 
However, to control for gender bias, the gender of the subjects was not known until after 
the groups had been established. 
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Table 2: Differential Grouping of Study Subjects. Study subjects assessed by 
development and grouped into categories based off of symptom severity to then 
be used for analysis. 
Category 
Total 
(n = 20) 
Males 
(n = 12) 
Females 
(n= 8) 
Typical, total (%) 
4 (20%) 0 (0%) 4 (50%) 
Borderline, total (%) 
8 (40%) 8 (67%) 0 (0%) 
ASD, total (%) 
5 (25%) 3 (25%) 2 (25%) 
Not enough information, total (%) 
3 (15%) 1 (8%) 2 (25%) 
 
Subjects with an autism diagnosis, which was confirmed by both the DSM-IV and 
ADOS, were grouped within the ASD group. Additionally, these subjects also met the 
criteria for autism within the PDD-BI. If a subject received a diagnosis of ASD from 
either diagnostic tool, but not confirmed through both, then they were placed in the 
borderline differential category. Of the subjects classified as borderline, 2 received a 
diagnosis from the DSM-IV: one was diagnosed with ASD and the other with PDD-NOS. 
Only one child had a diagnosis of ASD from the ADOS without a DSM confirmation. 
Subjects who received an ADOS calibrated score of 3, where the cut-off for diagnosis at 
3 years is a 4, were also included in the borderline group. 
A confirmation with the AOSI was used if a subject scored a 2 on the ADOS. Subjects 
who scored a 9 or above at 9 or 14 months, who have not been classified within the ASD 
group, were considered borderline. This also was confirmed by a DSM-IV diagnosis; two 
subjects that scored a 2 on the ADOS, considering them typical, received a DSM-IV 
diagnosis of autism, and a score of 9 or above at 9 months. Additionally, the AOSI was 
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also used if a subject had no differential diagnosis by either the DSM-IV or the ADOS at 
20, 24, or 30 months. If the subject scored an average of 9 or above between 9 and 4 
months, they were considered borderline. Lastly, the PDD-BI was referred to for two 
subjects who did not meet the criteria for ASD, with the above-mentioned methods, but 
scored very close to the cut-off on the AOSI. Subjects who scored within 2 points of the 
cut-off on the PDD-BI, or a standard deviation (SD) of 1.2 from the mean, were grouped 
as borderline.  
 
Subjects were considered typical if they did not meet criteria for ASD or borderline 
through either the PDD-BI, the AOSI, or the DSM-IV in the mentioned time-points, and 
if they scored a calibrated score of 1 or 2 on the ADOS.  
Three subjects were not able to be classified using any of these methods into one of the 
three groups due to limited data and were removed from further analysis. 
 
Confirmation of the Differential Groups 
Considering the predictive validity of the AOSI at 12 months, the AOSI scores at 9 and 
14 months were utilized to confirm the distribution among differential groups. In order to 
visualize the AOSI score at 9 and 14 months in the small sample size, bell curves in a 
normal distribution were created. The small sample size created a challenge in creating a 
normal distribution. To overcome this problem, Microsoft Excel 2013 was used to 
generate and increase the number of entries in the small data set, which were then used to 
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create Bell curves. The mean and standard deviation were first calculated from the 
sample, followed by the bin numbers, or values which represent the intervals used by the 
histogram in measuring the input generated data. The bin numbers reflect the AOSI 
scores. In order to create randomly generated numbers within the parameters of the small 
samples, the “Random Number” tool in Excel was used. Though this tool, 2000 variables 
were generated based off of the mean and standard deviation of every sample. All the 
generated samples reflect the original scores found in the original sample through the use 
of each group’s mean and standard deviation. Bell curves were created from the 
generated variables alongside the AOSI score, as determined by the bin numbers, through 
the use of the histogram tool. 
If each time point was not determined to be significant when correlated to the ADOS at 
30 months, an additional bell curve was constructed using ADOS calibrated scores at 30 
months to confirm the differential groups. 
 
CORRELATIONAL ANALYSIS 
AOSI and ADOS 
Focusing on the predicative validity of the AOSI at 12 months, the strength of the 
association between the AOSI scores at 9 and 14 month of the whole cohort and of 
individual differential groups (ASD, borderline and typical) were tested against the 
ADOS at 30 months (calibrated to 3 years of age), using Pearson correlation. The more 
significant correlation was used to confirm the designed groups. 
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Use of the Developmental Quotients in Correlations 
To understand development and the significance of DQs in the appearance of autistic-like 
symptoms, the DQs of all the subdomains found in the MSEL and VABS at 9 and 14 
months were used in correlations with the AOSI at 9 and 14 months using Pearson’s 
correlation coefficient. For a better understanding of the outcomes, the DQs at 30 months 
were correlated with the ADOS at 30 months.  
Lastly, the MSEL and VABS DQs at 9 and 14 months were correlated with ADOS at 30 
months, calibrated to 3 years of age to assess whether any developmental domain and 
time point tested in development has an association to the severity of autistic-like features 
at 30 months. Regression analysis was performed on all correlations to understand their 
significance. 
 
Trajectory Comparisons  
Standard scores were calculated for all DQs in the MSEL and VABS that showed 
significance from the previous analysis. These standard scores were then plotted for each 
diagnostic group as well as for the whole cohort across all time points. In addition, when 
considering groups separately, the ASD group was further subdivided by gender. All 
domains and subdomains in both assessments were considered. Differences between 
groups and scores were assessed.  
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RESULTS 
AOSI and ADOS 
Testing for correlation between the AOSI scores at 9 and 14 months and the ADOS 
scores at 30 months with each of the diagnostic groups as determined by the procedures 
described above shows no significance (Appendix 3). 
 
Assessing the diagnostic prediction of the AOSI at 9 months and at 14 months in the 
whole cohort, neither correlation to the ADOS at 30 months is significant. The AOSI at 9 
months shows a trend toward significance (p = 0.093) with a positive correlation (r = 
0.433) and with a mean of 7.94 on the AOSI. An AOSI score of 9 or above indicates that 
the child is at risk of developing autism. Of those in the ASD group, as determined by the 
criteria mentioned in the methods, the mean at 9 months is 12.2 (SD=3.63). The average 
for those in the borderline group is 7.88 (SD=3.94) and for the typical groups is 4.5 
(SD=2.89). AOSI at 14 months had a weak positive relationship when correlated to 
ADOS at 30 months (r = 0.0675) that was not significant (p = 0.818). Figures for both 
correlations can be found in Appendix 3.  
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CONFIRMATION OF DIFFERENTIAL GROUPS 
 
 
Figure 4: Normal Distribution of Subject Scores for AOSI at 9 Months. Scores of 
subjects were grouped through a normal distribution into three differential groups. 
 
 
Considering the trend in significance in AOSI at 9 months in relation to outcome scores 
in ADOS at 30 months, the AOSI at 9 months is used in this set of analyses to confirm 
the differential groups. The AOSI scores at 9 months in the ASD group are skewed to the 
right of the distribution for the borderline and typical samples (Figure 4). As is displayed 
through the histogram, the borderline group peaks at a score of 9, while the tails of the 
typical and ASD groups cross around the same score. A bell curve considering ADOS 
calibrated scores was also performed and included in Appendix 4. 
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ASSESSING DEVELOPMENT WITH AGE-MATCHED ASSESSMENTS 
Nine Months (Table 3) 
The Pearson correlation coefficients indicate that there is a correlation between DQ 
scores in certain subdomains and domains of the MSEL and the VABS with composite 
scores from the AOSI taken at 9 months and the ADOS taken at 30 months. This is seen 
in Table 3. All significant scores have a negative relationship due to higher scores being 
better in some tests and worse in others.   
Table 3:  Developmental Quotient (DQ) at Nine Months Correlation with Measures 
used to Assess Presence and Severity of Autism Features. Calculated DQs at 9 months 
in the MSEL and VABS were significantly correlated with the AOSI and ADOS at 9 and 
30 months, respectively. 
 
 
 
 
 
 
 
 
At 9 months, the composite MSEL verbal (r=-0.59, p=0.009) and non-verbal (r=-0.7, 
p=0.0006) DQ scores at 9 months are strongly correlated with the AOSI scores. Aside 
Assessment domains 
and subdomains 
Developmental Outcome 
AOSI 9 months ADOS 30 months 
MSEL 
Verbal  -0.59 ** -0.539 * 
   Expressive  -0.6 **  
Non-Verbal  -0.7 ***  
   Vis Rec  -0.648 **  
   Fine Motor  -0.7 ***  
VABS 
Socialization  -0.57 *  
   Interpersonal   
   Relationships 
 -0.51 *  
* correlation is significant at p<0.05 
**correlation is significant at p<0.01 
***correlation is significant at p<0.001 
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from a correlation of the composite DQs, a significant relationship between the AOSI at 9 
months and the subdomains, or the DQs scores, which are components of the composite 
scores, was noted; more specifically, expressive language (r=-0.6, p=0.007), falling under 
the verbal composite score, and both visual reception (r=-0.648, p=0.0037) and fine 
motor (r=-0.7, p=0.0006) DQ scores, which make up the non-verbal DQ composite score, 
were significantly correlated to AOSI at 9 months. 
 
In the VABS at 9 months, the only composite DQ score that shows significance when 
correlating to AOSI at 9 months is socialization (r=-0.57, p=0.022). A subdomain in 
socialization – the interpersonal relationships DQ (r=-0.51, p=0.042) – also demonstrated 
a significant correlation (Table 3). 
 
Fourteen Months (Table 4) 
At 14 months, only the MSEL verbal DQ (r=-0.702, p=0.004), along with the 
subdomains, receptive (r=-0.744, p=0.0015) and expressive language (r=-0.56, p=0.03), 
displayed any correlation when compared to the AOSI at 14 months (Table 4).   
However, when comparing the DQ scores from the MSEL and VABS at 14 months to the 
AOSI at 9 months, only the VABS but not the MSEL showed significant correlation to 
the assessment. The VABS was significant in three domains: communication (r=-0.61, 
p=0.021), daily living skills (r=-0.6, p=0.04), and socialization (r=-0.662, p=0.02). More 
specifically, the following subdomains demonstrated significance in relation to the AOSI 
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at 9 months: expressive language (r=-0.65, p=0.021), domestic skills (r=-0.6, p=0.04), 
play and leisure time (r=-0.593, p=0.04), and coping skills (r=-0.64, p=0.02). No DQs at 
14 months displayed any correlation with ADOS scores at 30 months. 
 
Table 4: Developmental Quotient (DQ) at Fourteen Months Correlation with 
Measures used to Assess Presence and Severity of Autism Features. Calculated DQs 
at 14 months in the MSEL and VABS which significantly correlated with the AOSI at 9 
and 14 months. 
 
Assessment domains 
and subdomains 
Developmental 
AOSI 9 months AOSI 14 months 
MSEL 
Verbal   -0.702 ** 
   Receptive   -0.744 ** 
   Expressive   -0.56 * 
VABS 
Communication  -0.61 *  
   Expressive  -0.65 *  
Daily Living Skills  -0.6 *  
   Domestic  -0.6 *  
Socialization  -0.662 *  
   Play and Leisure 
Time 
 -0.593 *  
   Coping Skills  -0.64 *  
* correlation is significant at p<0.05 
**correlation is significant at p<0.01 
***correlation is significant at p<0.001 
 
 
Thirty Months (Table 5) 
Using the ADOS at 30 months to correlate 30 month DQs from VABS and MSEL, only 
the VABS socialization subdomain, play and leisure (r=-0.58, p=0.029), showed 
significant correlation between tests (Table 5).   
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Table 5: Developmental Quotient (DQ) at Thirty Months: Correlation with Measure 
used to Assess Severity of Autism Features. Calculated DQ in the VABS showed 
significance when correlated with the ADOS at 30 months. 
 
 
 
 
 
 
OUTCOME PREDICTIVE MEASURES 
The Pearson correlation coefficient indicates that the MSEL Verbal composite DQ at 9 
months significantly correlates with the ADOS score at 30 months (r=-0.54, p=0.03), as 
displayed in Table 3. There was no significant correlation of the ADOS at 30 months 
with the MSEL or VABS DQ scores at 14 months. 
 
TRAJECTORY COMPARISON 
The standard scores of the MSEL verbal DQs, which showed the greatest significance 
when compared to the AOSI in the same time point, were plotted over all time points as a 
total average between groups. Though no significance was found when correlating each 
group separately with the AOSI and ADOS, it is important to understand how the groups 
vary in development over time. This is displayed in Figure 5. The ASD group was also 
Assessment domain 
and subdomain 
Outcome 
ADOS 30 months 
VABS 
Socialization  
   Play and Leisure  -0.58 * 
* correlation is significant at p<0.05 
**correlation is significant at p<0.01 
***correlation is significant at p<0.001 
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divided between males and females and plotted separately (Figure 6). Comparison 
between groups, the typical group scored maintained a standard score around 0, which 
the ASD and borderline groups had negative DQ standard scores (Figure 5). Within the 
ASD group, female subjects scored worse than males in both expressive and receptive 
language development, except at 9 months, where expressive language was higher 
(Figure 6). 
 
 
 
Figure 5: MSEL Verbal DQ Plotted for Each Group Over Time. Trajectory display 
of MSEL verbal DQ scores across groups. 
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Figure 6: MSEL Verbal DQ Plotted for ASD Group, Differentiating between 
Genders, Over Time. MSEL verbal DQs are lowest in the ASD group and, more 
specifically, lowest in girls who were diagnosed with autism.  
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DISCUSSION 
AOSI AT 9 MONTHS 
Though the AOSI is not a diagnostic tool, at 12 months, there is a strong predictive 
validity of diagnosis made at 3 years of age [62]. This study did not have a large enough 
sample size to support the use of the AOSI at 9 months as a method of determining future 
diagnoses. A larger sample size might contribute to a more significant correlation 
between the 9 months AOSI score and 30 month ADOS score. However, the ADOS, a 
“gold standard” for diagnosis, and the DSM-IV were used alongside the AOSI and PDD-
BI to supplement missing data when establishing the differential groups, which 
demonstrated distinct scores when plotted in a normal distribution for the AOSI at 9 
months; the ASD group was skewed to the far right, followed by the borderline group. A 
higher AOSI score means that more autistic-like features are present in an individual. 
This distribution, though displayed through generated scores based of the study’s sample 
scores, clearly distinguishes the differential groups. This is also confirmed through 
plotting ADOS calibrated scores at 30 months in a normal distribution (Appendix 4). The 
AOSI has not been tested previously at 9 months for predictive validity and future 
considerations in a larger sample size are recommended.  
 
DEVELOPMENTAL QUOTIENTS 
Comparing DQ measures with the AOSI at the same time points demonstrated which 
areas of development, as measured by the MSEL and the VABS, were most reflective of 
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children at risk of developing autism, as determined by the AOSI. The negative 
correlations represent a decrease in DQ as the presence of autistic-like characteristic 
increase.  
A cross-sectional look in a longitudinal study allows further insight on what is happening 
during that specific time point. At both 9 and 14 months, the strongest indicators of 
development that demonstrated autistic-like characteristics were found in socialization, 
communication, and language. At nine months, non-verbal development, as determined 
by the MSEL, was also demonstrated to identify children at risk. MSEL verbal and non-
verbal DQs might be good indicators of autism symptoms as they arise in high risk 
children at this specific time point. The MSEL domains, at 9 and 14 months, have a 
stronger correlation to the AOSI than the VABS. This may be an indicator that the MSEL 
DQs are more likely to identify autistic-like characteristics in children. Alternatively, this 
might also be a reflection of the similarity in behavioral assessment between screening 
tools at that time in development.  
At 30 months, the children were assessed using the ADOS, instead of the AOSI. 
Focusing on this time point, only the VABS subdomain, play and leisure, correlated 
significantly with the ADOS. Again, this might be a reflection of development at this 
specific time point, or a result of the similarity between assessments used to evaluate 
subjects during that time point. 
Interestingly, domains on the VABS at 14 months demonstrated correlational 
significance when compared to AOSI at 9 months. Through this correlation, it can be 
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inferred that the characteristics screened for in the AOSI at 9 months are complemented 
and displayed later in time with the VABS. This analysis would need to be considered at 
other time points, as well as applied to a later sample size. 
When looking at DQs and the likelihood of diagnosis at 30 months, only verbal assessed 
through the MSEL at 9 months demonstrated to be significant. At nine months, language 
developmental delays can be a sign of a future diagnosis.  
 
COMMUNICATION CAN LEAD TO PROBLEMS IN SOCIALIZATION 
Comparing cross-sectional time points at 9 and 30 months with the DQs correlations in 
the ADOS, verbal difficulties precede problems with socialization (more specifically, 
play and leisure). These behavioral and cognitive problems often are interrelated and 
impact each other. Furthermore, these problems might be caused by confounders not 
controlled through these assessments, such as physiological changes, which need to be 
further considered. 
 
TRAJECTORY DIFFERENCES 
Female subjects overall had a higher verbal DQ than males (Appendix 6). This reflects 
literature that females tend to score better verbally than males, and might cause some of 
them to be overlooked than to be considered on the spectrum. Since the typical group was 
comprised only of females and the borderline group comprised only with males, this 
might have biased the true effect of verbal DQ among groups. However, when focusing 
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on the ASD group, which is comprised of both females and males, females scored lower 
than males; females with ASD are more impacted developmentally than males with ASD. 
This is reflective of previous literature. 
 
DIFFICULTY IN ASSESSMENT 
The largest challenge in the statistical analysis for this study was the small sample size. A 
small sample size increases the impact of biases on the data, as well as limits sufficient 
statistical power to demonstrate significance. Low statistical power might decrease the 
reproducibility of these results, as well as overestimate the size of any effect [71].  
Studying a small cohort longitudinally impacted the correlational statistics. Including the 
scores of individuals who both regressed and improved in development overtime 
contradicted the expected outcome at 30 months. Larger sample sizes would control the 
impact of these changes in developmental outcome. However, this was also 
advantageous; these individuals were easily noticeable over time through behavioral 
assessments. With these select subjects, the physiological changes demonstrated by 
behavioral resilience or regression can be further investigated.  
This study was designed as a pilot study to capture biological and behavioral data 
pertinent to detecting early signs of autism. Aside for isolating novel trends for further 
investigation, the study was also intended to build infrastructure that could support a 
similar multidisciplinary study on a larger scale. Now that this infrastructure exists, future 
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studies with larger sample size will be more feasible. 
 
LIMITATIONS 
Mothers enrolled in this study already have at least one child diagnosed with autism. 
They are more aware of behavioral signs for autism and might put more emphasis on 
certain conditions, occurrences or events observed in the enrolled child, which may 
influence reported data. Though such alert parents may provide earlier insight in the onset 
of autistic-like features, as is intended in this study, this situation does not mirror a larger 
population. 
Furthermore, with a limited sample, time points with missing data created challenges in 
performing analyses. Lack of data made correlations between different time points less 
reliable; at every time point, scores of different subjects were compared, potentially 
creating different group effects. 
As time progressed in the study, the psychometricians, who administered the behavioral 
assessments, might have become accustomed to the series of assessments as well as the 
patients, which might influence how the data was recorded over time. Furthermore, 
subconscious subject comparison might create bias.  
Lastly, behavioral assessments have limitations with collecting and/or recording 
observational data. The ADOS, for example, allows the examiner to record what is 
observed only during the period the test is administered. This was the case with one 
subject; assessed through the ADOS, he was diagnosed on the spectrum, however, on the 
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DSM-IV, he was considered typical. If during time of assessment, the child behaves 
atypically compared to the norm, the problem behavior might be missed or 
overestimated. This problem can be circumvented by using tools which include different 
perspectives of a child’s development, such as from parents, teachers, and physicians, as 
well as tools that assess different areas of development.  
A challenge in this analysis, in regard to the changes observed, can also stem from the 
choice of tools used for comparison. For example, the most significance was found 
within the verbal scores. This can reflect the main behavioral observation in autism 
spectrum disorders, which is a lack of social interest and challenged communication. 
However, this may also result from the tools duplicating each other in assessing the same 
problems in development.  
 
FUTURE CONSIDERATIONS 
This thesis focused on a small subset of data collected throughout the study. These 
assessments can further be analyzed at earlier time points, using similar methods. The 
information attained through this work, such as the significance in verbal outcomes, can 
help focus scores gathered from other assessments, as well as look for assessments that 
would assess other compromised areas of development in autism, such as sensory and 
motor. Assessing multiple tools could allow insight on which tools are sensitive to the 
earliest onset of worrisome behaviors.  
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Ultimately, this assessment data will be analyzed alongside physiological information. 
Trajectory recordings of both the assessment scores and physiological measures can be 
compared to provide a more comprehensive understanding of the pathophysiology and 
behavioral manifestation in autism. 
The overall study was designed using a clinical (and indeed intensive multivariate 
clinical), rather than an epidemiological model. Phenotype within autism varies between 
individuals and considering cohorts based on diagnoses allows trends to be observed, but 
dismisses individual phenotypical differences. This is important to consider in a high risk 
sibling group because these children often either recover after displaying developmental 
signs of autism or start developing typically and later regress. These minute, yet 
monumental developmental changes, which can provide insight to the onset or the 
prevention of autism, are often missed in large epidemiological studies. Creating a study 
with a clinical, longitudinal perspective, focusing on individual trends and comparisons 
between developmental progressions within and across domains and classes of data, will 
shed some light on key developmental changes, allowing further focus on biomarkers 
which could mirror or precede observable behavior.  
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APPENDIX 1: Tissue Sample – Quantities Collected 
 
 
Infant 
Samples 
2 wks 8 wks 4 mos 9 mos 14 mos 20 mos 30 mos 
Urine 14 13 15 18 13 12 10 
Saliva 5 14 16 16 15 11 13 
Buccal swap 13 13 17 19 14 15 14 
Hair 6 8 10 15 15 15 15 
Nails 5 8 12 14 15 14 10 
Stool 6 6 6 1 5 6 3 
Blood (Filter 
Paper) 
11 12 15 17 12 13 14 
 
 
Maternal 
Samples 
Pre-
natal 
2 wks 8 wks 4 mos 9 mos 
14 
mos 
20 
mos 
30 
mos 
Urine 17 11 12 15 16 14 12 14 
Saliva 17 12 14 16 17 14 11 10 
Buccal swap 17 11 12 14 16 13 13 13 
Breast Milk n/a 7 7 9 3 1 0 0 
Hair 5 6 5 6 14 12 10 9 
Nails 15 8 11 11 13 13 9 7 
Blood 
(Phlebotomy) 
19 0 4 2 10 2 2 0 
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APPENDIX 2: Full List of Assessments 
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APPENDIX 3: Correlation of Developmental and Outcome Measures 
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APPENDIX 4: Bell Curve with Calibrated ADOS Scores 
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APPENDIX 5: MSEL DQ Scores across Groups at Nine Months 
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APPENDIX 6: MSEL Verbal DQ Trajectories by Gender 
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